In educational frameworks, DSIP is positioned at most for the patient with documented, persistent sleep-architecture problems who has genuinely failed sleep hygiene, CBT-I, and melatonin, and who explicitly understands they would be engaging with something investigational rather than a validated treatment
The relevant analytical framework follows the ICH Q6B guidance for peptide drug substances, which covers reporting of identity, purity, content, and impurity profiles
Intriguingly, LL-37 also has anti-inflammatory properties in certain contexts, making it a dual-natured molecule
Heart rate changes Increased heart rate has been noted as a potential side effect of cagrilintide, consistent with observations across the broader class of weight loss medications